Fabre-Kramer Pharmaceuticals focuses on compounds to license-in, develop for global registration, and license-out to commercial partners. Fabre-Kramer then creates life-cycle management strategies to maximize the commercial potential of those compounds. It was formed to identify, develop, and commercialize psychotropic drugs with significant market potential. The Company’s principals have over 40 years of experience in the c...
Fabre-Kramer Pharmaceuticals focuses on compounds to license-in, develop for global registration, and license-out to commercial partners. Fabre-Kramer then creates life-cycle management strategies to maximize the commercial potential of those compounds. It was formed to identify, develop, and commercialize psychotropic drugs with significant market potential. The Company’s principals have over 40 years of experience in the clinical development of psychotropic drugs and have conducted pivotal studies of many drugs approved by the FDA in psychiatry.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.